
               
               
               7	DRUG INTERACTIONS
               
                  



               



               
               
                  
                     
                        
                           CYP3A4, CYP2C9, and CYP2C19 inhibitors and inducers: Adjust VFEND dosage and monitor for adverse reactions or lack of efficacy (4, 7)
                           VFEND may increase the concentrations and activity of drugs that are CYP3A4, CYP2C9 and CYP2C19 substrates. Reduce dosage of these other drugs and monitor for adverse reactions (4, 7)
                           Phenytoin or Efavirenz: with co-administration, increase maintenance oral and intravenous dosage of VFEND (2.3, 7)
                        
                     
                  
               
            
         